发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report SABCS 2022最新文献

筛选
英文 中文
Endocrine interruption to pursue pregnancy does not impact short-term disease in breast cancer 中断内分泌以追求妊娠对乳腺癌患者的短期疾病没有影响
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/2ce7ae0e
Marten Dooper
{"title":"Endocrine interruption to pursue pregnancy does not impact short-term disease in breast cancer","authors":"Marten Dooper","doi":"10.55788/2ce7ae0e","DOIUrl":"https://doi.org/10.55788/2ce7ae0e","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123816646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baseline CTC count can guide first-line treatment in HR-positive/HER-negative metastatic breast cancer 基线CTC计数可以指导hr阳性/ her阴性转移性乳腺癌的一线治疗
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/b136268f
Marten Dooper
{"title":"Baseline CTC count can guide first-line treatment in HR-positive/HER-negative metastatic breast cancer","authors":"Marten Dooper","doi":"10.55788/b136268f","DOIUrl":"https://doi.org/10.55788/b136268f","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132092841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefit of adjuvant abemaciclib continues to deepen at longer follow-up 在更长时间的随访中，abemaciclib辅助治疗的获益继续加深
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/c9ec2496
Marten Dooper
{"title":"Benefit of adjuvant abemaciclib continues to deepen at longer follow-up","authors":"Marten Dooper","doi":"10.55788/c9ec2496","DOIUrl":"https://doi.org/10.55788/c9ec2496","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115819466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment options beyond CDK4/6 inhibition CDK4/6抑制之外的治疗选择
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/dd13faa3
Marten Dooper
{"title":"Treatment options beyond CDK4/6 inhibition","authors":"Marten Dooper","doi":"10.55788/dd13faa3","DOIUrl":"https://doi.org/10.55788/dd13faa3","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133374680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-PD-1/anti-LAG-3 combination highly effective in HER2-negative breast cancer 抗pd -1/抗lag -3联合治疗her2阴性乳腺癌疗效显著
Medicom Conference Report SABCS 2022 Pub Date : 2023-02-01 DOI: 10.55788/22a25a2a
Marten Dooper
{"title":"Anti-PD-1/anti-LAG-3 combination highly effective in HER2-negative breast cancer","authors":"Marten Dooper","doi":"10.55788/22a25a2a","DOIUrl":"https://doi.org/10.55788/22a25a2a","url":null,"abstract":"","PeriodicalId":163367,"journal":{"name":"Medicom Conference Report SABCS 2022","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125223880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信